World
Takeda and Protagonist's Mimrylo approved for polycythemia vera Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
Dr. Kai NakamuraChief Science CorrespondentPublished Aug 30, 2026 at 6:23 PM EDT · 1 min read
Takeda and Protagonist's Mimrylo approved for polycythemia vera Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera. Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.